<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">human</item><item key="factors"><item><item key="GSM492826"><item key="CELL TYPE">Embryonic Stem Cells (hESCs)</item><item key="DEVELOPMENTAL STAGE">embroynic</item></item></item><item><item key="GSM492826"><item key="CELL TYPE">Embryonic Stem Cells (hESCs)</item><item key="DEVELOPMENTAL STAGE">embroynic</item></item></item><item><item key="GSM492828"><item key="CELL TYPE">hESC-derived Endothelial Cells</item><item key="DEVELOPMENTAL STAGE">embroynic</item></item></item><item><item key="GSM492828"><item key="CELL TYPE">hESC-derived Endothelial Cells</item><item key="DEVELOPMENTAL STAGE">embroynic</item></item></item><item><item key="GSM492828"><item key="CELL TYPE">hESC-derived Endothelial Cells</item><item key="DEVELOPMENTAL STAGE">embroynic</item></item></item><item><item key="GSM492828"><item key="CELL TYPE">hESC-derived Endothelial Cells</item><item key="DEVELOPMENTAL STAGE">embroynic</item></item></item><item><item key="GSM492832"><item key="CELL TYPE">umbilical vein endothelial cell</item><item key="DEVELOPMENTAL STAGE">mature</item></item></item><item><item key="GSM492832"><item key="CELL TYPE">umbilical vein endothelial cell</item><item key="DEVELOPMENTAL STAGE">mature</item></item></item><item><item key="GSM492832"><item key="CELL TYPE">umbilical vein endothelial cell</item><item key="DEVELOPMENTAL STAGE">mature</item></item></item><item><item key="GSM492832"><item key="CELL TYPE">umbilical vein endothelial cell</item><item key="DEVELOPMENTAL STAGE">mature</item></item></item><item><item key="GSM492836"><item key="CELL TYPE">Cord Blood CD34+ Cells</item><item key="DEVELOPMENTAL STAGE">mature</item></item></item><item><item key="GSM492836"><item key="CELL TYPE">Cord Blood CD34+ Cells</item><item key="DEVELOPMENTAL STAGE">mature</item></item></item></item><item key="id">3542</item><item key="pop_total">0</item><item key="platform">4</item><item key="summary_wrapped">The pathways involved in hierarchical differentiation of human embryonic stem cells (hESC) into abundant and durable endothelial cells...</item><item key="pubmed_id">20081865</item><item key="geo_gse_id">E-GEOD-19735</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">12</item><item key="tags"><item>cadherin</item><item>cell</item><item>embryonic stem cell</item><item>line</item><item>serum</item><item>stem cell</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_id_plat">E-GEOD-19735_A-AFFY-44</item><item key="slug">comparison-of-human-embroynic-stem-cell-derived-va</item><item key="geo_gds_id"/><item key="name">Comparison of human embroynic stem cell derived vascular cells to mature human vascular and hematopoietic cells</item><item key="created">Sep.15, 2014</item><item key="summary">The pathways involved in hierarchical differentiation of human embryonic stem cells (hESC) into abundant and durable endothelial cells (EC) are unknown. We employed an EC-specific VE-cadherin promoter driving GFP (hVPr-GFP) to screen for factors that augmented yields of vascular-committed ECs from hESCs. In phase 1 of our approach, inhibition of TGFb, precisely at day 7 of hESC differentiation, enhanced emergence of hVPr-GFP+ ECs by 10-fold. In the second phase, TGFb-inhibition preserved proliferation and vascular identity of purified ECs, resulting in net 36-fold expansion of homogenous EC-monolayers, and allowing transcriptional profiling that revealed a unique angiogenic signature defined by the VEGFR2highId1highVE-cadherin+EphrinB2+CD133+HoxA9- phenotype. Using an Id1-YFP hESC reporter line, we showed that TGFb-inhibition sustained Id1 expression in hESC-derived ECs, which was required for increased proliferation and preservation of EC commitment. These data provide a multiphasic method for serum-free differentiation and long-term maintenance of authentic hESC-derived ECs, establishing clinical-scale generation of transplantable human ECs. The experiment compared 6 sets of biological duplicates which included human embryonic stem cell derived and mature vascular cell types.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-19735</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-19735/samples/</item></data></biogps>
